Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 USD | -5.96% | -6.94% | +170.03% |
18/04 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
06/03 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+170.03% | 108M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.52% | 21.25B | |
-5.99% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Cantor Fitzgerald Starts Rezolute at Overweight With $9 Price Target